THE PREVALENCE OF HYPERTENSION AMONG HIV PATIENTS UNDER ANTIRETROVIRAL THERAPY AT CENTER FOR TROPICAL DISEASES, BACH MAI HOSPITAL

Duy Cường Đỗ 1,2, Thu Trà Đoàn 1,
1 Bach Mai hospital
2 VNU Hanoi-University of Medicine and Pharmacy

Main Article Content

Abstract

Introduction: HIV infection and long-term antiretroviral therapy have been found to be associated with an increased risk factors for cardiovascular disease. This study was conducted with the aim to determine the prevalence of high blood pressure and associated factors in HIV/AIDS patients on long-term antiretroviral therapy at the Center for Tropical Diseases, Bach Mai Hospital. Participants and Methods: A cross-sectional descriptive study was performed on 286 HIV/AIDS outpatients at the Center for Tropical Diseases, Bach Mai Hospital. The study period is from January 2021 to June 2021. Results: The overall rate of hypertension was 14.3%, of which grade 1 hypertension was 8.7%, grade 2 was 3.9% and grade 3 was 1.8%, respectively. The prevalence of hypertension is higher in men than in women. In which, the rates of grade 1, grade 2 and grade 3 hypertension in men were 11.5%, 5.4% and 3.0%, respectively. Multivariable logistic regression analysis showed that the odds ratio for hypertension was lower in women (aOR=0.52; p<0.001), higher in the age group ≥41 (aOR=44.43-151.08; p<0.001) and the patient smoked (aOR=1.01; p=0.05). Overweight/obesity status and diabetes mellitus have also been shown to be associated with hypertension in patients. Conclusion: Given the increasing trend of "aging" of HIV-infected people in Vietnam, screening for hypertension and chronic diseases should be routinely performed at HIV outpatient clinics for early detection and referral.

Article Details

References

1. Shah, A.S.V., et al., Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV. Circulation, 2018. 138(11): p. 1100-1112.
2. Farahani, M., et al., Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis. Int J STD AIDS, 2017. 28(7): p. 636-650.
3. Smith, C.J., et al., Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet, 2014. 384(9939): p. 241-8.
4. Xu, Y., X. Chen, and K. Wang, Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis. J Am Soc Hypertens, 2017. 11(8): p. 530-540.
5. Meiqari, L., et al., Prevalence of Hypertension in Vietnam: A Systematic Review and Meta-Analysis. Asia-Pacific journal of public health, 2019. 31(2): p. 101-112.
6. Mayer, K.H., et al., Excess Clinical Comorbidity Among HIV-Infected Patients Accessing Primary Care in US Community Health Centers. Public Health Rep, 2018. 133(1): p. 109-118.
7. Mosha, N.R., et al., Prevalence,awareness and factors associated with hypertension in North West Tanzania. Glob Health Action, 2017. 10(1): p. 1321279.
8. Davis, K., et al., Association between HIV infection and hypertension: a global systematic review and meta-analysis of cross-sectional studies. BMC Medicine, 2021. 19(1): p. 105.